Evaluate patients for treatment of neurological and musculoskeletal disorders.Analyze decisions made throughout the diagnosis and treatment of patients with neurological and musculoskeletal disorders.

Discussion Board PART I :ADHD AND PART II :Generalized anxiety disorder

Discuss the following psychological, neurological, and musculoskeletal diseases. see below for the objectives for the week.

Evaluate patients for treatment of psychological disorders

Analyze decisions made throughout the diagnosis and treatment of patients with psychological disorders

Analyze impacts of pharmacotherapeutics for psychological disorders on patient pathophysiology

Evaluate patients for treatment of neurological and musculoskeletal disorders

Analyze decisions made throughout the diagnosis and treatment of patients with neurological and musculoskeletal disorders

Justify decisions made throughout the diagnosis and treatment of patients with neurological and musculoskeletal disorders

Evaluate patients for treatment of psychological disorders

Analyze decisions made throughout the diagnosis and treatment of patients with psychological disorders

Analyze impacts of pharmacotherapeutics for psychological disorders on patient pathophysiology

Evaluate patients for treatment of neurological and musculoskeletal disorders

Analyze decisions made throughout the diagnosis and treatment of patients with neurological and musculoskeletal disorders

Examine potential impacts of pharmacotherapeutics used in the treatment of GAD. Consider factors that might have influenced the patient’s pharmacokinetic and pharmacodynamic processes, such as genetics (including pharmacogenetics), gender, ethnicity, age, behavior, and/or possible pathophysiological changes due to disease.